海正药业与圣兆药物设立复杂注射剂合资公司

Core Viewpoint - On October 30, Haizheng Pharmaceutical and Shengzhao Pharmaceuticals signed a cooperation agreement to jointly invest in establishing a joint venture focused on complex injectable drugs in Taizhou, Zhejiang Province [1] Group 1: Investment Details - Haizheng Pharmaceutical plans to invest 495 million yuan, holding a 45% stake in the joint venture [1] - Shengzhao Pharmaceuticals intends to invest 605 million yuan, holding a 55% stake in the joint venture [1] Group 2: Joint Venture Focus - The joint venture will primarily research, produce, and commercialize 11 complex injectable products, including complex injectable generics and modified new drugs [1] - Haizheng Pharmaceutical will have the right of first cooperation for future related products from Shengzhao Pharmaceuticals [1]